01 — Platform
Microalgae Platform
A proprietary microalgae production platform engineered for high-purity EPA development at scale. Renewable, traceable, and biologically optimized.
- Proprietary cultivation
- High-purity EPA
- Scalable & sustainable
Where Algae MeetsAdvanced Therapeutics
Therapeutic solutions from microalgae combining advanced lipid science and natural cannabinoid research for mental and neurological health.
30+
Years of Research
100%
Plant-Based
EPA
Only Formulation
Scroll
Scientific Advantage
Where nature meets advanced therapeutics
Three converging disciplines — microalgae biology, polar lipid chemistry, and cannabinoid research — engineered into one therapeutic platform.
02 — Innovation
EPA Innovation
EPA-only formulations with highly polar lipid architecture for superior bioavailability. Non-fish derived. Designed for therapeutic precision.
- EPA-only formulation
- Highly polar lipids
- Therapeutic-grade purity
03 — Synergy
Cannabinoid Synergy
Research-driven synergy between EPA and cannabinoid pathways — investigating enhanced functionality, improved signaling, and therapeutic optimization.
- Pathway synergy
- Signaling research
- Therapeutic optimization
Therapeutic Applications
A pipeline rooted in precision biology
Research programs investigating the therapeutic potential of microalgae-derived EPA across mental and neurological health.
01Discovery
Mental Health Support
EPA-driven modulation research targeting mood, cognition, and emotional regulation pathways.
02Preclinical
Neurological Health
Investigating neuronal membrane integrity and lipid signaling for long-term neurological support.
03Research
Neuroinflammation
Exploring polar EPA's role in modulating neuroinflammatory cascades and microglial activity.
04Emerging
Cannabinoid Synergy
Combinatorial pipeline studying EPA × cannabinoid signaling for next-generation therapeutic platforms.
Research & Evidence
Peer-reviewed. Institutionally rigorous.
Lipid Science
Polar EPA bioavailability vs. conventional fish-derived omega-3
Comparative pharmacokinetic review · 2024→
Neuroscience
EPA modulation of neuronal membrane fluidity in cortical models
Preclinical research summary · 2023→
Cannabinoid
Endocannabinoid–EPA signaling: a synergistic pathway hypothesis
Mechanistic review · 2024→
Sustainability
Biotech infrastructure that regenerates
Sustainability is not a claim — it is the architecture. Renewable cultivation replaces extractive marine harvesting with engineered, scalable, low-impact production.
0
Marine harvesting
No pressure on ocean ecosystems.
100%
Renewable cultivation
Closed-loop microalgae systems.
Low
Environmental footprint
Optimized water and energy use.
Scale
Industrial readiness
Engineered for global supply.
About Algae Pharma
A research institution
building living therapeutics.
Algae Pharma develops next-generation therapeutic innovations from microalgae — combining advanced lipid science and cannabinoid research to support mental and neurological health.
Innovation
Pioneering microalgae-derived therapeutics.
Scientific Excellence
Rigor across every experimental layer.
Collaboration
Partnerships with leading institutions.
Sustainability
Engineered for planetary balance.